{"domain":"definiumtx.com","status":"valid","tier":"listed","authority":51,"verified":false,"title":"Definium Therapeutics","summary":"Therapeutic treatment for brain health disorders","country":"US","country_source":"ip","llms_txt":"https://definiumtx.com/llms.txt","llms_full_txt":null,"last_checked":"2026-10-20T20:48:58.719Z","agent_terms":null,"categories":["healthcare"],"capabilities":[],"inferred_tags":["brain health","therapeutics","clinical trials","drug pipeline","expanded access"],"audience":"mixed","agent_uses":["search_content","contact_support"],"language":"en","platform_generated":false,"agent_summary":"Definium Therapeutics: biopharma developing treatments for brain health disorders, with pipeline (DT120, DT402), clinical trial and expanded access info.","llms_txt_cached":"https://agentwebmap.com/v1/domain/definiumtx.com/llms.txt","agentic":"informational","section_keys":["general","news","people"],"section_partial":false,"section_indexed_at":"2026-10-21T14:09:17.756Z"}